MedTrace Logo

Corneal Thinning During Topical Bevacizumab Therapy

NCT00515684 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2015-05-01

No results posted yet for this study

Summary

The purpose of this study is to determine whether topical bevacizumab is safe or not when used in corneal neovascularization for long term period.

Conditions

  • Corneal Neovascularization

Interventions

DRUG

bevacizumab (Avastin)

Sponsors & Collaborators

  • Yonsei University

    lead OTHER

Principal Investigators

  • Sang Woo Kim, M.D. · Severance hospital, Seoul , Korea

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00515684 on ClinicalTrials.gov